The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Constipation Market Research Report 2025
Synopsis
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
The global Constipation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
This report aims to provide a comprehensive presentation of the global market for Constipation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Constipation.
Report Scope
The Constipation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Constipation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Constipation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong Pharmaceuticals
Bayer
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Segment by Type
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Constipation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
The global Constipation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
This report aims to provide a comprehensive presentation of the global market for Constipation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Constipation.
Report Scope
The Constipation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Constipation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Constipation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong Pharmaceuticals
Bayer
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Segment by Type
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Constipation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Constipation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chronic Idiopathic Constipation (CIC)
1.2.3 Irritable Bowel Syndrome With Constipation (IBS-C)
1.2.4 Opioid-Induced Constipation (OIC)
1.3 Market by Application
1.3.1 Global Constipation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Constipation Market Perspective (2019-2030)
2.2 Constipation Growth Trends by Region
2.2.1 Global Constipation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Constipation Historic Market Size by Region (2019-2024)
2.2.3 Constipation Forecasted Market Size by Region (2025-2030)
2.3 Constipation Market Dynamics
2.3.1 Constipation Industry Trends
2.3.2 Constipation Market Drivers
2.3.3 Constipation Market Challenges
2.3.4 Constipation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Constipation Players by Revenue
3.1.1 Global Top Constipation Players by Revenue (2019-2024)
3.1.2 Global Constipation Revenue Market Share by Players (2019-2024)
3.2 Global Constipation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Constipation Revenue
3.4 Global Constipation Market Concentration Ratio
3.4.1 Global Constipation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Constipation Revenue in 2023
3.5 Constipation Key Players Head office and Area Served
3.6 Key Players Constipation Product Solution and Service
3.7 Date of Enter into Constipation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Constipation Breakdown Data by Type
4.1 Global Constipation Historic Market Size by Type (2019-2024)
4.2 Global Constipation Forecasted Market Size by Type (2025-2030)
5 Constipation Breakdown Data by Application
5.1 Global Constipation Historic Market Size by Application (2019-2024)
5.2 Global Constipation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Constipation Market Size (2019-2030)
6.2 North America Constipation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Constipation Market Size by Country (2019-2024)
6.4 North America Constipation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Constipation Market Size (2019-2030)
7.2 Europe Constipation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Constipation Market Size by Country (2019-2024)
7.4 Europe Constipation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Constipation Market Size (2019-2030)
8.2 Asia-Pacific Constipation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Constipation Market Size by Region (2019-2024)
8.4 Asia-Pacific Constipation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Constipation Market Size (2019-2030)
9.2 Latin America Constipation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Constipation Market Size by Country (2019-2024)
9.4 Latin America Constipation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Constipation Market Size (2019-2030)
10.2 Middle East & Africa Constipation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Constipation Market Size by Country (2019-2024)
10.4 Middle East & Africa Constipation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Constipation Introduction
11.1.4 Takeda Pharmaceutical Revenue in Constipation Business (2019-2024)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Synergy Pharmaceuticals
11.2.1 Synergy Pharmaceuticals Company Detail
11.2.2 Synergy Pharmaceuticals Business Overview
11.2.3 Synergy Pharmaceuticals Constipation Introduction
11.2.4 Synergy Pharmaceuticals Revenue in Constipation Business (2019-2024)
11.2.5 Synergy Pharmaceuticals Recent Development
11.3 Sucampo Pharmaceuticals
11.3.1 Sucampo Pharmaceuticals Company Detail
11.3.2 Sucampo Pharmaceuticals Business Overview
11.3.3 Sucampo Pharmaceuticals Constipation Introduction
11.3.4 Sucampo Pharmaceuticals Revenue in Constipation Business (2019-2024)
11.3.5 Sucampo Pharmaceuticals Recent Development
11.4 Ironwood Pharmaceuticals
11.4.1 Ironwood Pharmaceuticals Company Detail
11.4.2 Ironwood Pharmaceuticals Business Overview
11.4.3 Ironwood Pharmaceuticals Constipation Introduction
11.4.4 Ironwood Pharmaceuticals Revenue in Constipation Business (2019-2024)
11.4.5 Ironwood Pharmaceuticals Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Detail
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Constipation Introduction
11.5.4 Bausch Health Revenue in Constipation Business (2019-2024)
11.5.5 Bausch Health Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Constipation Introduction
11.6.4 Abbott Revenue in Constipation Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Constipation Introduction
11.7.4 AstraZeneca Revenue in Constipation Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Cosmo Pharmaceuticals
11.8.1 Cosmo Pharmaceuticals Company Detail
11.8.2 Cosmo Pharmaceuticals Business Overview
11.8.3 Cosmo Pharmaceuticals Constipation Introduction
11.8.4 Cosmo Pharmaceuticals Revenue in Constipation Business (2019-2024)
11.8.5 Cosmo Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Constipation Introduction
11.9.4 Sanofi Revenue in Constipation Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Daewoong Pharmaceuticals
11.10.1 Daewoong Pharmaceuticals Company Detail
11.10.2 Daewoong Pharmaceuticals Business Overview
11.10.3 Daewoong Pharmaceuticals Constipation Introduction
11.10.4 Daewoong Pharmaceuticals Revenue in Constipation Business (2019-2024)
11.10.5 Daewoong Pharmaceuticals Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer Constipation Introduction
11.11.4 Bayer Revenue in Constipation Business (2019-2024)
11.11.5 Bayer Recent Development
11.12 Prestige Brands Holdings
11.12.1 Prestige Brands Holdings Company Detail
11.12.2 Prestige Brands Holdings Business Overview
11.12.3 Prestige Brands Holdings Constipation Introduction
11.12.4 Prestige Brands Holdings Revenue in Constipation Business (2019-2024)
11.12.5 Prestige Brands Holdings Recent Development
11.13 Janssen Pharmaceutical
11.13.1 Janssen Pharmaceutical Company Detail
11.13.2 Janssen Pharmaceutical Business Overview
11.13.3 Janssen Pharmaceutical Constipation Introduction
11.13.4 Janssen Pharmaceutical Revenue in Constipation Business (2019-2024)
11.13.5 Janssen Pharmaceutical Recent Development
11.14 Shionogi
11.14.1 Shionogi Company Detail
11.14.2 Shionogi Business Overview
11.14.3 Shionogi Constipation Introduction
11.14.4 Shionogi Revenue in Constipation Business (2019-2024)
11.14.5 Shionogi Recent Development
11.15 Albireo Pharma
11.15.1 Albireo Pharma Company Detail
11.15.2 Albireo Pharma Business Overview
11.15.3 Albireo Pharma Constipation Introduction
11.15.4 Albireo Pharma Revenue in Constipation Business (2019-2024)
11.15.5 Albireo Pharma Recent Development
11.16 Renexxion
11.16.1 Renexxion Company Detail
11.16.2 Renexxion Business Overview
11.16.3 Renexxion Constipation Introduction
11.16.4 Renexxion Revenue in Constipation Business (2019-2024)
11.16.5 Renexxion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
